A Pharmacokinetic & Pharmacodynamic Study of Oral Lenalidomide in Patients with Low- or Intermediate-1-Risk Myelodysplastic Syndromes

被引：0
作者：
Wu, Anfan
List, Alan
Lush, Richard
Bretz, Kelly
Knight, Robert
Lau, Henry
Zeldis, Jerry
机构：
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4854
引用
收藏
页码：299B / 299B
页数：1
相关论文
共 50 条
  • [31] Analysis of Second Primary Malignancies in Lenalidomide-Treated Patients with IPSS Low- or Int-1-Risk Myelodysplastic Syndromes
    Giagounidis, Aristoteles
    Raza, Azra
    List, Alan F.
    Fenaux, Pierre
    Benettaib, Bouchra
    Brown, Benton
    Zhong, Jim
    Brandenburg, Nancy
    Mufti, Ghulam J.
    BLOOD, 2011, 118 (21) : 742 - 743
  • [32] CLINICAL FACTORS PREDISPOSING TO ACHIEVEMENT OF RBC TRANSFUSION INDEPENDENCEIN LENALIDOMIDE-TREATED PATIENTS WITH LOW/INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES) WITHOUT DEL(5q) IN MDS-005 STUDY
    Santini, V.
    Li, J. Shiansong
    Swern, A. S.
    Almeida, A.
    Giagounidis, A.
    Fu, T.
    Sanna, A.
    Hoenekopp, A.
    Beach, C. L.
    Skikne, B.
    Fenaux, P.
    HAEMATOLOGICA, 2015, 100 : 3 - 4
  • [33] MDS-005 STUDY: EFFECT OF BASELINE ENDOGENOUS ERYTHROPOIETIN ON RBC TRANSFUSION INDEPENDENCE IN LENALIDOMIDE-TREATED PATIENTS WITH LOW OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES WITHOUT DEL(5Q)
    Santini, V.
    Li, J. S.
    Swern, A. S.
    Almeida, A.
    Giagounidis, A.
    Fu, T.
    Hoenekopp, A.
    Beach, C.
    Skikne, B.
    Fenaux, P.
    HAEMATOLOGICA, 2015, 100 : 69 - 69
  • [34] Phase 2 Study of Monotherapy Galunisertib (LY2157299 Monohydrate) in Very Low-, Low-, and Intermediate-Risk Patients with Myelodysplastic Syndromes
    Valcarcel, David
    Verma, Amit
    Platzbecker, Uwe
    Santini, Valeria
    Giagounidis, Aristoteles
    Diez-Campelo, Maria
    Janssen, Jan
    Schlenk, Richard F.
    Gaidano, Gianluca
    Perez de Oteyza, Jaime
    Cleverly, Ann L.
    Chiang, Alan Y.
    Lahn, Michael
    Desiaih, Durisala
    Guba, Susan C.
    List, Alan F.
    Komrokji, Rami S.
    BLOOD, 2015, 126 (23)
  • [35] A phase 2/3 trial of oral azacitidine (Oral-AZA) in patients (pts) with low- or intermediate-risk myelodysplastic syndromes (MDS)
    Garcia-Manero, Guillermo
    Santini, Valeria
    Fenaux, Pierre
    Suzuki, Takahiro
    Sekeres, Mikkael A.
    He, Jun
    Barkalifa, Ronit
    Vigil, Carlos Enrique
    Prebet, Thomas
    Komrokji, Rami S.
    Giagounidis, Aristoteles
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] Randomized Open-Label Phase II Study of Decitabine in Patients With Low- or Intermediate-Risk Myelodysplastic Syndromes
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Borthakur, Gautam
    Faderl, Stefan
    Estrov, Zeev
    Yang, Hui
    Maddipoti, Sirisha
    Godley, Lucy A.
    Gabrail, Nashat
    Berdeja, Jesus G.
    Nadeem, Ahmed
    Kassalow, Laurent
    Kantarjian, Hagop
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) : 2548 - +
  • [37] Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes
    Santini, Valeria
    Valcarcel, David
    Platzbecker, Uwe
    Komrokji, Rami S.
    Cleverly, Ann L.
    Lahn, Michael M.
    Janssen, Jan
    Zhao, Yumin
    Chiang, Alan
    Giagounidis, Aristoteles
    Guba, Susan C.
    Gueorguieva, Ivelina
    Girvan, Allicia C.
    Ferreira, Mariana da Silva
    Bhagat, Tushar D.
    Pradhan, Kith
    Steidl, Ulrich
    Sridharan, Ashwin
    Will, Britta
    Verma, Amit
    CLINICAL CANCER RESEARCH, 2019, 25 (23) : 6976 - 6985
  • [38] Imetelstat: drugging telomerase in transfusion-dependent low- and intermediate-1-risk MDS
    Cannova, Joseph
    Madero-Marroquin, Rafael
    Odenike, Olatoyosi
    BLOOD ADVANCES, 2025, 9 (06) : 1390 - 1391
  • [39] Results of a Randomized, Double-Blind Study of Romiplostim Versus Placebo in Patients With Low/Intermediate-1-Risk Myelodysplastic Syndrome and Thrombocytopenia
    Giagounidis, Aristoteles
    Mufti, Ghulam J.
    Fenaux, Pierre
    Sekeres, Mikkael A.
    Szer, Jeffrey
    Platzbecker, Uwe
    Kuendgen, Andrea
    Gaidano, Gianluca
    Wiktor-Jedrzejczak, Wieslaw
    Hu, Kuolung
    Woodard, Paul
    Yang, Allen S.
    Kantarjian, Hagop M.
    CANCER, 2014, 120 (12) : 1838 - 1846
  • [40] A Randomized Study Comparing Stem Cell Transplantation Versus Conventional Therapy for Low- and Intermediate-Risk Myelodysplastic Syndromes Patients
    Yu, Zheng-Ping
    Ding, Jia-Hua
    Sun, Ai-Ning
    Ge, Zheng
    Chen, Bao-An
    Wu, De-Pei
    STEM CELLS AND DEVELOPMENT, 2017, 26 (15) : 1132 - 1139
12345